Companies / Confluence Pharmaceuticals
Confluence Pharmaceuticals
Company
Confluence Pharmaceuticals develops novel therapeutic treatments for core social and communication impairments caused by Fragile X Syndrome, Autism, and other disorders.
Confluence Pharmaceuticals has 2 investors on file, among them Elevate Ventures and IU Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Investor |
More from Elevate Ventures
258 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (22%), AI & Machine Learning (17%), Education (11%).
See Elevate Ventures' full profile · Who invests alongside it
More from IU Ventures
49 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (32%), Education (14%), Enterprise Software (8%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Confluence Pharmaceuticals and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Elevate Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/confluencepharma.com/investors
# also
GET /v1/companies/confluencepharma.com
GET /v1/companies/confluencepharma.com/news